INTERNATIONAL PATENT: REZOLUTE, INC. FILES APPLICATION FOR "INSULIN RECEPTOR MODULATION FOR TUMOR ASSOCIATED HYPERINSULINISM"

GENEVA, Aug. 19 -- REZOLUTE, INC. (201 Redwood Shores PkwySuite 315Redwood City, California 94065) filed a patent application (PCT/US2025/015227) for "INSULIN RECEPTOR MODULATION FOR TUMOR ASSOCIATED HYPERINSULINISM" on Feb 10, 2025. With publication no. WO/2025/171378, the details related to the patent application was published on Aug 14, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): HOOD, Davelyn Eaves (201 Redwood Shores PkwySuite 315Redwood City, California 94065), AKANA, Cody Keoki (201 Redwood Shores PkwySuite 315Redwood City, California 94065), BREIT, Jeffrey Francis (201 Redwood Sh...